Tag Archives: APOP

Best Value Stocks To Invest In Right Now

New York, NY, based Investment company Standard General L.P. buys Turning Point Brands Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Standard General L.P.. As of 2018-03-31, Standard General L.P. owns 4 stocks with a total value of $89 million. These are the details of the buys and sells.

Added Positions: NCMI, TPB,

For the details of Standard General L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 14,387,113 shares, 83.65% of the total portfolio. Shares added by 8.59%Turning Point Brands Inc (TPB) – 455,319 shares, 9.92% of the total portfolio. Shares added by 49.13%CafePress Inc (PRSS) – 2,500,000 shares, 3.77% of the total portfolio. Emmis Communications Corp (EMMS) – 515,231 shares, 2.66% of the total portfolio. Added: Turning Point Brands Inc (TPB)

Standard General L.P. added to a holding in Turning Point Brands Inc by 49.13%. The purchase prices were between $19.44 and $22.38, with an estimated average price of $21.12. The stock is now traded at around $25.96. The impact to a portfolio due to this purchase was 3.27%. The holding were 455,319 shares as of 2018-03-31.

Best Value Stocks To Invest In Right Now: Meridian Bioscience Inc.(VIVO)

Advisors’ Opinion:

  • [By Logan Wallace]

    VIVO (CURRENCY:VIVO) traded down 0.1% against the dollar during the 24 hour period ending at 0:00 AM Eastern on May 8th. In the last seven days, VIVO has traded down 9.4% against the dollar. One VIVO coin can now be bought for about $0.77 or 0.00008506 BTC on major cryptocurrency exchanges including Cryptopia, CryptoBridge and Stocks.Exchange. VIVO has a market cap of $1.41 million and approximately $9,560.00 worth of VIVO was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Meridian Bioscience (VIVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Intellia Therapeutics (NASDAQ: NTLA) and Meridian Bioscience (NASDAQ:VIVO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Best Value Stocks To Invest In Right Now: Franklin Financial Network, Inc.(FSB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Franklin Financial Network (FSB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Franklin Financial Network Inc. (NYSE: FSB) was downgraded to sell from neutral at Compass Point. The stock has traded in a 52-week range of $30.30 to $42.65. The consensus price target for the company across Wall Street is $37.80. The stock closed Monday at $39.40, a rise of more than 5%.

  • [By Stephan Byrd]

    ValuEngine lowered shares of Franklin Financial Network (NYSE:FSB) from a hold rating to a sell rating in a research report sent to investors on Monday.

  • [By Max Byerly]

    Franklin Financial Network (NYSE:FSB) was downgraded by research analysts at Compass Point from a “neutral” rating to a “sell” rating in a research note issued on Tuesday, The Fly reports.

Best Value Stocks To Invest In Right Now: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Best Value Stocks To Invest In Right Now: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Anders Bylund]

    Finisar(NASDAQ:FNSR) followed in AAOI’s footsteps in March, surging more than 10% higher around the announcement of Lumentum’s Oclaro deal, but losing it all amid deafening radio silence. By the end of March, the stock had fallen 12.2% lower, and Finisar has not enjoyed any glowing analyst analyses in April.

  • [By Ezra Schwarzbaum]

    Finisar Corporation (NASDAQ: FNSR) was up 2.9 percent Monday morning. The stock had fallen 4 percent on the Commerce Department news in April.

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

  • [By Anders Bylund]

    The maker of optical networking components was off to a good start in March, but it lost all momentum when rival Finisar (NASDAQ:FNSR) reported weak earnings with mellow management comments on the state of the optical market. Finisar shares plunged 23% lower the next day, dragging Oclaro down in a 13% three-day slide.

Best Value Stocks To Invest In Right Now: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Enbridge (NYSE:ENB) has hit a rough patch in recent years. While cash flow and its dividend have continued rising, shares have slumped about 20% since the start of 2018 and are down more than 40% from their peak in 2015. Because of that, Enbridge’s valuation has declined to a very inexpensive level, which when combined with a steady stream of dividend increases, has pushed its yield up to an eye-catching 6.7%. That high yield for a cheap price makes Enbridge look like a compelling stock to buy, especially considering all the growth it has coming down the pipeline.

  • [By Matthew DiLallo]

    Several high-yielding dividend stocks have taken it on the chin this year due to a sell-off in the stock market and rising interest rates. That one-two punch has hit pipeline stocks the hardest, with several top-notch companies tumbling by a double-digit percentage since the start of the year. Three that stand out as excellent options to consider buying now that they’re on sale are Magellan Midstream Partners (NYSE:MMP), Antero Midstream Partners (NYSE:AM), and Enbridge (NYSE:ENB).

  • [By Matthew DiLallo]

    Last November, Enbridge (NYSE:ENB) outlined its three-year strategic and financial plan. One of the key components of the Canadian pipeline giant’s strategy was selling 3 billion Canadian dollars’ ($2.3 billion as of May 9, 2018) worth of non-core assets in 2018, which would give it some of the cash needed to finance its CA$22 billion ($17 billion) expansion plan. That would enable the company to reduce debt while still growing cash flow and the dividend at a 10% compound annual rate through 2020.

  • [By Matthew DiLallo]

    Oil prices have improved dramatically over the past year as OPEC’s move to drain off the supply glut proved more successful than envisioned. That rising tide has lifted most oil stocks. However, that doesn’t mean investors have missed the boat, since many oil stocks still have ample upside. Two top ones where that’s the case are Devon Energy (NYSE:DVN) and Enbridge (NYSE:ENB).

  • [By Paul Ausick]

    Calgary-based energy infrastructure company Enbridge Inc. (NYSE: ENB) on Thursday made a nonbinding offer to acquire the approximately 17% of Spectra Energy Partners L.P. (NYSE: SEP) it does not already own in a deal that would pay unitholders of Spectra 1.0123 shares of Enbridge common stock for every common unit of Spectra they currently hold.

Best Value Stocks To Invest In Right Now: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Shane Hupp]

    Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

  • [By Stephan Byrd]

    Media stories about CELLECT BIOTECH/S (NASDAQ:APOP) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CELLECT BIOTECH/S earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3583768207142 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

day trading options

If you want to know how and where a company will strategically spend its time, money and efforts, then look no further than how it makes its money. So, tomorrow when Facebook’s (NASDAQ:FB) Developer Conference, dubbed F8, kicks off, don’t be surprised if payments isn’t the star of the show.

Except for when

For that, you’ll have to read on. I’ve read that cliffhangers that build slowly are all the rage now.

Named after Facebook’s infamous dusk-to-dawn, eight-hour Hackathons, F8 is an annual confab intended to give developers a look at new tools that will help them reach and engage the 1.9 billion and 1.2 billion unique people who now visit Facebook every month and every day, respectively.

Over those two days, it seems a near certainty that those developers will hear more about the things that Mark Zuckerberg laid out in his F8 keynote last year: how to make video more plentiful and engaging, how to use AI to make user experiences more meaningful and personalized, how to use AR/VR to create new user experiences and what Facebook is doing to give the 4 billion people in the world who don’t have Internet access today the chance to get it inexpensively.

day trading options: Apache Corporation(APA)

Advisors’ Opinion:

  • [By Chris Lange]

    Apache Corp. (NYSE: APA) fourth-quarter results are scheduled for Thursday. The consensus forecast is for $0.22 in EPS on $1.55 billion in revenue. Shares were trading at $38.11. The consensus price target is $50.43. The 52-week range is $35.70 to $56.51.

  • [By ]

    Now, I haven’t dabbled in U.S. shale oil or in the permian basin since I extracted myself from Apache (APA) several months ago after an epic fight in the name of capital preservation. But The Wall Street Journal ran a piece last week explaining that due to already-mentioned distribution bottlenecks, Permian-basin oil prices had fallen below $60 a barrel despite the fact that WTI futures were trading above $70.

  • [By VantagePoint]

    Apache Corporation (NYSE: APA) has been ripping since March 2nd, when it hit a two-year low of $33.60. Since then it's up 25 percent. 

    The three-month chart below shows that this trend is likely to continue. The blue line is generated via VantagePoint's intermarket analysis, and represents a prediction of what APA's moving average will be in three days. The black line is a simple 10-day moving average. Note the bullish crossover that occurred in early March. That was a signal that the stock was entering an uptrend. 

  • [By Paul Ausick]

    Apache Corp. (NYSE: APA) dropped about 7.3% Thursday to post a new 52-week low of $34.50. Shares closed at $37.20 on Wednesday and the stock’s 52-week high is $55.23. Volume was over 11 million, about three times the daily average of around 3.9 million. The company reported quarterly results this morning, but investors were not impressed.

day trading options: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Travis Perkins (OTCMKTS: TVPKF) and Lumber Liquidators (NYSE:LL) are both retail/wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

  • [By Ethan Ryder]

    Lumber Liquidators Holdings (NYSE:LL) – Oppenheimer upped their FY2018 earnings per share (EPS) estimates for shares of Lumber Liquidators in a report issued on Tuesday, May 1st. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will post earnings of $0.80 per share for the year, up from their prior estimate of $0.70.

day trading options: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

day trading options: MicroStrategy Incorporated(MSTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MicroStrategy (MSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Watch Right Now

Over in DigiTimes, contributor Nebojsa Novakovic recently speculated that gaming-oriented graphics processors based on NVIDIA’s (NASDAQ:NVDA) recently announced Volta architecture could use a type of video memory known as HBM2 (“high bandwidth memory 2”) rather than a more traditional graphics double data rate (GDDR) memory.

HBM2 memory is believed to be more expensive to produce than traditional GDDR-type memory, but the idea is that HBM2 is said to offer power efficiency and physical footprint advantages over GDDR-type memories.

Image source: NVIDIA.

Today, NVIDIA’s GP100 chip — which powers the company’s Tesla P100 datacenter accelerator and its Quadro GP100 professional visualization accelerator — uses HBM2, while the company’s gaming-oriented Pascal products (GP102, GP104, GP106, GP107, GP108) use either GDDR5X (for higher-end products) or GDDR5 (for lower-end products).

Top 10 Heal Care Stocks To Watch Right Now: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Heal Care Stocks To Watch Right Now: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped about 5.4% Thursday, to post a new 52-week low of $22.78 after closing at $24.07 on Wednesday. The stock’s 52-week high is $51.93. Volume was about 3 times the daily average of around 1.1 million shares. The company had no specific news, but the troubles at Fitbit may be spilling over.

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 21% Wednesday, to post a new 52-week low of $18.10 after closing at $22.87 on Tuesday. The stock’s 52-week high is $51.93. Volume was about 15 times the daily average of around 1.2 million shares. The company reported so-so results last night and Wells Fargo cut its rating on the stock to Underperform this morning.

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble. 

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 25% Wednesday to post a new 52-week low of $13.65 after closing at $18.15 on Tuesday. The stock’s 52-week high is $36.87. Volume was more than 5 times the daily average of around 1.9 million shares. The company missed analysts’ expectations bigly this morning.

Top 10 Heal Care Stocks To Watch Right Now: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

Top 10 Heal Care Stocks To Watch Right Now: Barracuda Networks, Inc.(CUDA)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap security and storage solutions stock Barracuda Networks Inc (NYSE: CUDA) reported fiscal Q2 2018 earnings after the market closed Tuesday that were largely in-line, but shares are falling more than 6% in afterhours/premarket trading. Q2 total revenue grew 7% to $94.3 million as subscription revenue grew 14% to $76.0 million representing 81% of total revenue while appliance revenue was $18.3 million versus $21.0 million. GAAP net income was $1.6 million versus GAAP net income of $2.4 million. The CEO commented:

  • [By Chris Lange]

    Barracuda Networks Inc. (NYSE: CUDA) fiscal first-quarter results are scheduled for Monday. The consensus earnings estimate is $0.18 per share, on $91.15 million in revenue. The shares were last seen at $23.85. The consensus price target is $28.56, and the 52-week trading range is $18.67 to $26.69.

  • [By Jayson Derrick]

    It is unclear which company or companies will benefit from this executive order. But that isn’t stopping investors from placing their bets as most cybersecurity stocks were trading higher during Friday’s trading session; at the same time, the Dow Jones Industrial Average and S&P 500 index were trading in the red.

    Shares of Barracuda Networks Inc (NYSE: CUDA) were trading higher by 2.98 percent at $21.77. Shares of Check Point Software Technologies Ltd. (NASDAQ: CHKP) were trading higher by 1.21 percent at $107.00. Shares of FireEye Inc (NASDAQ: FEYE) were trading higher by 0.70 percent at $14.55. Shares of Palo Alto Networks Inc (NYSE: PANW) were trading higher by 0.62 percent at $115.86.

    Related Links:

  • [By Peter Graham]

    The Q3 2017 earnings report for small cap security and storage solutions stock Barracuda Networks Inc (NYSE: CUDA) is scheduled for after the market closes onMonday (October 9th) with shares rising 9% the last time around on a good earnings report.

Top 10 Heal Care Stocks To Watch Right Now: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Brian Stoffel]

    Last week, management at Veeva Systems (NYSE:VEEV) reported earnings that investors have become accustomed to. In fact, shareholders have been downright spoiled: both the top and bottom lines came in ahead of expectations; annual sales growth from Veeva’s non-CRM division came in at a blistering 113%.

  • [By Brian Stoffel]

    To say that Veeva Systems (NYSE:VEEV) has performed well as a publicly traded company would be an understatement. While the stock itself is actually down since its post-IPO days, the company’s fundamentals have vastly improved during that time frame.

  • [By Brian Stoffel]

    HR and payroll specialist Paycom Software (NYSE:PAYC), mortgage software provider Ellie Mae (NYSE:ELLI), and cloud computing king for drug companies Veeva Systems (NYSE:VEEV) are the three best software companies you could buy in 2017. They share three key traits that any investor can love: high switching costs, blazing growth rates, and founders or CEOs with lots of skin in the game.

  • [By Peter Graham]

    Mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) reported fiscal Q1 2018 earnings after the market closed yesterday with earningsbeating expectations. Total revenuesincreased 32% to$157.9 million as subscription services revenues rose 33% to $127.3 million whilenet incomeincreased 57% to $36.0million. The CEO commented:

Top 10 Heal Care Stocks To Watch Right Now: region(DGLD)

Advisors’ Opinion:

  • [By Jim Robertson]

    The VelocityShares 3x Inverse Gold ETN (NASDAQ: DGLD) seeks to provideshort exposure to three times (3x) the daily performance of theS&P GSCI Gold Index. As with UGLD, DGLD would be doing this viafutures contracts.

Top 10 Heal Care Stocks To Watch Right Now: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Top 10 Heal Care Stocks To Watch Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

Top 10 Heal Care Stocks To Watch Right Now: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2.9% Wednesday to post a new 52-week low of $8.01after closing Tuesday at $8.25. The 52-week high is $10.15. Volume of around 4.7 million shares traded was more than triple the daily average. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2% Wednesday to post a new 52-week low of $4.95 after closing at $5.05 on Tuesday. The 52-week high is $10.15. Volume was around 4 million, about 40% above the daily average of around 2.9million. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) also matched a 52-week low of $3.90 Monday. The stock’s 52-week high is $10.15. Volume of about 1.7 million was about 20% below the daily average. The company had no specific news. The stock is set to close up about 0.3% today.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 11.8% Thursday to post a new 52-week low of $8.55 after closing at $9.69 on Wednesday. The stock’s 52-week high is $10.15. Volume was nearly 20 times the daily average of around 1.9 million shares. The company, which is in the process of liquidating its assets in New York City, announced quarterly results Wednesday afternoon, including a liquidation value of the portfolio of $9.25 per share.

Top 10 Heal Care Stocks To Watch Right Now: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top 10 Medical Stocks To Watch For 2018

Gladstone, NJ, based Investment company Murphy Capital Management Inc buys SPDR Select Sector Fund – Consumer Discretionary, Bristol-Myers Squibb Company, SPDR Select Sector Fund – Industrial, Lear, OSI Systems, SPDR Select Sector Fund – Consumer Staples, Siemens AG, CBS, iShares MSCI Emerging Index Fund, FedEx, sells Xylem, Time Warner, St Jude Medical, Mead Johnson Nutrition Co, Becton, Dickinson and Co during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Murphy Capital Management Inc. As of 2017-03-31, Murphy Capital Management Inc owns 266 stocks with a total value of $660 million. These are the details of the buys and sells.

New Purchases: LEA, OSIS, CBS, FEZ, ACWI, ACIA, CNC, ETN, GLW, ADBE, Added Positions: XLY, BMY, XLI, XLP, SIEGY, AMZN, FB, EEM, FDX, FEU, Reduced Positions: AAPL, XYL, TWX, BDX, SBUX, HD, UPS, XLV, DIS, EL, Sold Out: STJ, MJN, JCI, GATX, GPC, BT, PX, TM, OKE, OTEX,

For the details of MURPHY CAPITAL MANAGEMENT INC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=MURPHY+CAPITAL+MANAGEMENT+INC

Top 10 Medical Stocks To Watch For 2018: iShares Core S&P Mid-Cap (IJH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Lubar & Co., Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc

    These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota

Top 10 Medical Stocks To Watch For 2018: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Lisa Levin]

    CRH Medical Corp (NYSE: CRHM) was down, falling around 31 percent to $2.55 after the company disclosed financial and operating results for the quarter and six months ended June 30, 2017.

Top 10 Medical Stocks To Watch For 2018: 3M Company(MMM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Lisa Levin]

    3M Co (NYSE: MMM) agreed to sell substantially all of its communication markets division to Corning Incorporated (NYSE: GLW) for $900 million.

    Corning expects the deal adding $0.07 to $0.09 per share in FY19 earnings.

  • [By Shanthi Rexaline]

    Here is the list of the Dow components, which are scheduled to report this week:

    1. 3M Co
    Company: 3M Co (NYSE: MMM). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $2.54 versus $2.08. Revenue Estimate: $7.86 billion versus $7.66 billion. Stock Gain/Loss (year to date): 18.12 percent.
    2. Caterpillar
    Company: Caterpillar Inc. (NYSE: CAT). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.25 versus $1.09. Revenue Estimate: $10.93 billion versus $10.94 billion. Stock Gain/Loss (year to date): 16.10 percent.
    3. McDonald’s
    Company: McDonald’s Corporation (NYSE: MCD). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.62 versus $1.45. Revenue Estimate: $5.96 billion versus $6.26 billion. Stock Gain/Loss (year to date): 25.35 percent.
    4. United Technologies
    Company: United Technologies Corporation (NYSE: UTX) Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.78 versus $1.82. Revenue Estimate: $15.24 billion versus $14.87 billion. Stock Gain/Loss (year to date): 12.47 percent.

    See also: 3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season

Top 10 Medical Stocks To Watch For 2018: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Top 10 Medical Stocks To Watch For 2018: Unifi, Inc.(UFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unifi, Inc. (NYSE: UFI) shares were also up, gaining 18 percent to $26.92 as the company announced Q3 earnings of $0.56 per share on revenue of $161.3 million.

Top 10 Medical Stocks To Watch For 2018: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    For those that are looking to express a more downbeat market view, or looking for a source of funds, we can neutralize our positive S&P 500 outlook and aim to sell stocks that are at risk to underperform on a relative basis. While a rising tide lifts all boats in absolute terms, we found that mega-cap safety is the central theme linking stocks that are at, or nearing, decade-long relative lows vs. the S&P 500: General Electric, Southern (SO), Simon Property Group (SPG), Verizon Communications (VZ), Wal-Mart, ExxonMobil. We see such relative weakness as a sign of vulnerability in their trend.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By WWW.MONEYSHOW.COM]

    Southern Company (SO) produces 44,000 megawatts of generating capacity and 1,500 billion cubic feet of combined natural gas consumption and throughput volume.

Top 10 Medical Stocks To Watch For 2018: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.

  • [By Lisa Levin]

    Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.

Top 10 Medical Stocks To Watch For 2018: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Chris Lange]

    T-Mobile US, Inc. (NASDAQ: TMUS) reported first quarter financial results after markets closed Monday. The company said that it had $0.80 in diluted GAAP earnings per share (EPS) and $9.61 billion in revenue, versus consensus estimates from Thomson Reuters that called for $0.34 in EPS and $9.62 billion in revenue. The same period from last year had $0.56 in EPS and $8.6 billion in revenue.

  • [By WWW.THESTREET.COM]

    Donald Trump’s election has proved a boon for shareholders of Sprint (S) , on the premise that a Republican administration would be open to a merger of the carrier to T-Mobile USA (TMUS) . Regulators under Obama had pushed back against Sprint Chairman Masayoshi Son’s goal of combining the U.S.’s third- and fourth-largest carriers.

  • [By Money Morning Staff Reports]

    SoftBank also purchased telecom upstart Sprint Corp. (NYSE: S) in 2013. And it is considering deals with other communications giants, including Charter Communications Inc. (Nasdaq: CHTR) and T-Mobile U.S. Inc. (Nasdaq: TMUS)

Top 10 Medical Stocks To Watch For 2018: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares rose 47.1 percent to $3.22 in pre-market trading after jumping 54.23 percent on Wednesday.
    Digital Power Corporation (NYSE: DPW) rose 27.6 percent to $0.800 in pre-market trading after gaining 9.79 percent on Wednesday.
    Social Reality Inc (NASDAQ: SRAX) shares rose 23.1 percent to $7.16 in the pre-market trading session after surging 37.59 percent on Wednesday.
    China Auto Logistics Inc (NASDAQ: CALA) rose 16.9 percent to $4.15 in pre-market trading after gaining 4.11 percent on Wednesday.
    Riot Blockchain Inc (NASDAQ: RIOT) rose 15.1 percent to $18.40 in pre-market trading after climbing 42.01 percent on Wednesday.
    Seven Stars Cloud Group Inc (NASDAQ: SSC) rose 14.5 percent to $2.85 in the pre-market trading session after gaining 0.40 percent on Wednesday.
    Affimed NV (NASDAQ: AFMD) shares rose 14.3 percent to $2.40 in pre-market trading after gaining 4.88 percent on Wednesday.
    Corecivic Inc (NYSE: CXW) rose 10.2 percent to $25.56 in pre-market trading after climbing 0.65 percent on Wednesday.
    LM Funding America, Inc. (NASDAQ: LMFA) rose 9.6 percent to $3.30 in pre-market trading after surging 34.98 percent on Wednesday.
    U.S. Global Investors, Inc. (NASDAQ: GROW) rose 7.2 percent to $3.30 in pre-market trading after dropping 8.06 percent on Wednesday.
    Xunlei Ltd (NASDAQ: XNET) rose 6.8 percent to $25.61 in pre-market trading after climbing 11.74 percent on Wednesday.
    Net 1 UEPS Technologies Inc (NASDAQ: UEPS) shares rose 5.9 percent to $13.00 in pre-market trading after gaining 21.34 percent on Wednesday.
    Addus Homecare Corporation (NASDAQ: ADUS) rose 5.5 percent to $35.60 in pre-market trading after gaining 3.69 percent on Wednesday.
    TOP SHIPS Inc (NASDAQ: TOPS) rose 5.2 percent to $0.528 in pre-market trading after falling 10.36 percent on Wednesday.
    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) rose 4.7 percent to $14.11 in pre-market trading. Teva Pharma
  • [By Lisa Levin]

    Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

Top 10 Medical Stocks To Watch For 2018: Geopark Ltd(GPRK)

Advisors’ Opinion:

  • [By Dustin Parrett]

    As a service to our readers, we’ve put together a list of 10 cheap oil stocks under $5. Here are the stocks, share prices, and year-to-date (YTD) returns for each:

    Vallourec Sp (OTCMKTS ADR: VLOWY); $1.42; +13.6% YTDIthaca Energy Inc. (TSE: IAE); $1.93; +14.5% YTDSandRidge Permian Trust (NYSE: PER); $3.45; +16.95% YTDGeopark Ltd. (NYSE: GPRK); $5.06; +17.4% YTDGastar Exploration Inc. (NYSEMKT: GST); $1.89; +22.26% YTDAscent Resources Plc. (LON: AST); $2.11; +25.53% YTDErin Energy Corp. (NYSEMKT: ERN); $3.94; +29.1% YTDChesapeake Granite Wash Trust (NYSE: CHKR); $3.25; +38.3% YTDSouthcross Energy Partners LP (NYSE: SXE); $2.27; +68.15% YTDBonanza Creek Energy Inc. (NYSE: BCEI); $2.27; +122.55% YTD

    This list of oil stocks contains some highly speculative plays, so we can’t recommend buying them.